Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs

American Journal of Physiology

Volumn 274, Issue 1 PART 2, 1998, Pages

  Forfia, Paul R ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DOG; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DOGS; ESCHERICHIA COLI; FEMALE; HEART; HEART RATE; HEMODYNAMIC PROCESSES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRITES; STROKE VOLUME; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 0031890083     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.1.h193     Document Type: Article

References (41)

1. Aarden, L. A., P. M. Landsdorp, and E. R. deGroot. A growth factor for B-cell hybridomas produced by human monocytes. Lymphokines 10:175-185,1985.
2. Bernstein, R. D., P. R. Forfla, X. Xu, and T. H. Hintze. Endogenous NO modulates myocardial oxygen consumption during increased cardiac work in response to norepinephrine infusion in awake dogs (). FASEB J. 10:4667,1996.
3. Beutler, B., N. Krochin, I. W. Milssark, C. Luedke, and A. Cerami. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977-979, 1986.
4. Brady, A. J., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. Nitric oxide within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1963-H1966,1992.
5. Brobmann, G. F., H. B. Ulano, L. B. Hinshaw, and E. D. Jacobson. Mesenteric and vascular responses to -endotoxin in the monkey and dog. Am. J. Physiol. 219:1464-1467,1970.
6. Cobb, J. P., C. Natanson, Z. Quezado, W. D. Huffman, C. A. Koev, S. Banks, R. Correa, R. Levi, R. J. Elin, J. M. Hosseini, and R. L. Danner. Differential hemodynamic effects of L-NMMAin endotoxemic and normal dogs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1634-H1642,1995.
7. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389,1992.
8. Fong, Y., K. J. Tracey, L. L. Moldawer, D. G. Hesse, K. B. Manogue, J. S. Kenney, A. T. Lee, G. C. Kuo, A, C. Allison, S. F. Lowry, and .A. Cerami. Antibodies to cachectin/tumor necrosis factor reduce interleukin Iβ and interleukin 6 appearance during lethal bacteremia. J. Exp. Med. 170: 1627-1633, 1989.
9. Forsgren, P., and J. Modig. Lung mechanics with relation to pulmonary haemodynamics, gas exchange and extravascular lung water in mechanically ventilated endotoxaemic pigs. Acta Chir. Scand. 152:561-568,1986.
10. Gerritsen, M. E., and M. Printz. Sites of prostaglandin synthesis in the bovine heart and isolated coronary microvessels. Circ. Res. 49:1152-1163,1981.
11. Giroir, B. P. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit. Care Med. 21:780-789,1993.
12. Hall, R. C., and R. L. Hodge. Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs. J. Physiol. (Land.) 213:69-84,1970.
13. Hinshaw, L. B., L. T. Archer, J. Greenfield, and C. A. Guenter. .Effects of endotoxin on myocardial hemodynamics, performance, and metabolism. Am. J. Physiol. 221: 504-510, 1971.
14. Hinshaw, L. B., T. E. Emerson, Jr., P. F. lampietro, and C. M. Brake. A comparative study of the hemodynamic actions of histamine and endotoxin. Am. J. Physiol. 203:600-606,1962.
15. Hinshaw, L. B., T. E. Emerson, Jr., and D. A. Reins. Cardiovascular responses of the primate in endotoxin shock. ,Am. J. Physiol. 210: 335-340,1966.
16. Hinshaw, L. B., R. P. Gilbert, H. Kuida, and M. B. Visscher. Peripheral resistance changes and blood pooling after endotoxin in eviscerated dogs. Am. J. Physiol. 195:631-634,1958.
17. Kilbourn, R. G., A. Jubran, S. S. Gross, O. W. Griffith, R. Levi, J. Adams, and R. F. Lodato. Reversal of endotoxinmediated shock by AT-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172: 11321138,1990.
18. 2 uptake after inhibition of EDRF/NO synthesis. J. Appl. Physiol. 76:1166-1171,1994.
19. Liu, S., I. M. Adcock, R. W. Old, P. J. Barnes, and T. W. Evans. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196:1208-1213,1993.
20. Mahler, F., J. Ross, Jr., R. A. O'Rourke, and J. W. Covell. Effects of acute changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am. J. Cardiol. 35:626-634,1975.
21. Molloy, R. G., J. A. Mannick, and M. L. Rodrick. Cytokines, sepsis and immunomodulation. Br. J. Surg. 80:289-297,1993.
22. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-141,1991.
23. Morris, S. M., Jr., and T. R. Billiar. New insights into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E829-E839,1994.
24. Nies, A. S., R. P. Forsyth, II. E. Williams, and K. L. Melmon. Contribution of kinins to endotoxin shock in unanesthetized rhesus monkeys. Circ. Res. 22:155-164,1968.
25. Natanson, C., P. W. Eichenholz, R. L. Danner, P. Q. Eichacker, W. D. Hoffman, G. C. Kuo, S. M. Banks, T. J. MacVittie, and J. E. Parillo. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169:823-832,1989.
26. Quinones, M. A., W. II. Gaasch, and J. K. Alexander. Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation 53:293-301,1976.
27. Salvemini, D., R. Korbut, E. Anggard, and J. Vane. Immediate .release of a nitric oxide-like factor from bovine aortic éndothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87:2593-2597,1990.
28. Salvemini, D., S. L. Settle, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br. J. Pharmacol. 114: 1171-1178,1995.
29. Santhanam, U., C. Avila, R. Romero, H. Viguet, N. Ida, S. Sakawi, and P. B. Sehgal. Cytokines in normal and abnormal parturition: elevated amniotic fluid IL-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine 3:155-163,1991.
30. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105:575-580,1992.
31. Seyedi, N., X. Xu, A. Nasjletti, and T. H. Hiutze. Coronary kinin generation mediates nitric oxide release after angiotensin receptot stimulation. Hypertension 26:164-170,1995.
32. Shen, W. Q., X. Xu, M. Ochoa, G. Zhao, M. S. Wolin, and T. H. t Hintze. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ. Res. 75:1086-1095,1994.
33. Stuehr, D. J., and M. A. Marietta. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82: 7738-7742,1985.
34. Szabo, C., A. L. Salzman, and H. Ischiropoulos. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEES Lett. 363:235-238,1995.,
35. Szabo, C., C. C. Wu, S. S. Gross, C. Thiemermann, and J. Vane. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur. J. Pharmacol. 250:157-160, 1993.
36. 36a.Ungureanu-Longrois, D., J. L. Balligand, R. A. Kelly, and T. W. Smith. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J. Mol. Cell. Cardiol. 27:155-167,1995.
37. Van der Poll, T., and S. F. Lowry. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 3:'1-12,1995.
38. Walley, K. R., P. C. Hébert, Y. Wakai, P. G. Wilcox, J. D. Road, and D. J. Cooper. Decrease in left ventricular contractility after tumor necrosis factor-a infusion in dogs. J. Appl. Physiol. 76: 1060-1067,1994.
39. Weil, M. H., L. D. MacLean, M. B. Visscher, and W. W. Spink. Studies on the circulatory changes in the dog produced by endotoxin from gram-inegative microorganisms. J. Clin. Invest. 35:1191-1198,1956.
40. Wright, C. E., D. D. Rees, and S. Moncada. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:48-57,1992.
41. Zeballos, G. A., R. D. Bernstein, C. I. Thompson, P. R. Forfia, N. Seyedi, W. Q. Shen, P. M. Kaminski, M. S. Wolin, and T. H. Hintze. Pharmacodynamics of plasma nitrate/nitrite as an indicator of nitric oxide formation in conscious dogs. Circulation 91:2982-2988,1995.